The Therapeutic Effects of Intravitreal Bevacizumab in a Patient with Recalcitrant Idiopathic Polypoidal Choroidal Vasculopathy

Author： Ghajarnia Mehdi   Kurup Shree   Eller Andrew  

Publisher： Informa Healthcare

ISSN： 0882-0538

Source： Seminars in Ophthalmology, Vol.22, Iss.2, 2007-04, pp. : 127-131

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Short-Term Safety and Efficacy of a Single Intravitreal Bevacizumab Injection for the Management of Polypoidal Choroidal Vasculopathy

By  

Ophthalmologica, Vol. 223, Iss. 2, 2008-11 ,pp. : 85-92

Karger

Access to resources Recommend Favorite

Eplerenone in the Treatment of Polypoidal Choroidal Vasculopathy

By  

Case Reports in Ophthalmology, Vol. 6, Iss. 3, 2015-12 ,pp. : 477-481

Karger

Access to resources Recommend Favorite

Photodynamic Therapy Combined with Intravitreal Injection of Vascular Endothelial Growth Factor Antibody for Polypoidal Choroidal Vasculopathy

By  

Ophthalmologica, Vol. 225, Iss. 3, 2011-01 ,pp. : 169-175

Karger

Access to resources Recommend Favorite

Two-Year Results of Photodynamic Therapy Combined with Intravitreal Anti-Vascular Endothelial Growth Factor for Polypoidal Choroidal Vasculopathy

By  

Ophthalmologica, Vol. 226, Iss. 4, 2011-09 ,pp. : 205-213

Karger

Access to resources Recommend Favorite

One-Year Results of Intravitreal Ranibizumab with or without Photodynamic Therapy for Polypoidal Choroidal Vasculopathy

By  

Ophthalmologica, Vol. 226, Iss. 3, 2011-07 ,pp. : 119-126

Karger

Access to resources Recommend Favorite